I was thinking after the interest from Constance Capital and the AFR article that it makes sense for a PE bid.
Board is still in flux.
P/E ratio is trading at half multiple to the medical device peers.
Lots of upside is still on the table due to dysfunction from the board and not executing.
At least 3-5x sales potential if run right according to my numbers.
What does everyone else think about a PE buyout? Last bid was at $4.65 by a US group
I am not sure if I would sell to PE at the moment as I think it should be at least $30
Add to My Watchlist
What is My Watchlist?